BJP Evidence-Based Mental Health
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals
 QUICK SEARCH:   [advanced]


     


Journal of Mental Science (1961) 107: 115-118. doi: 10.1192/bjp.107.446.115
© 1961 The Royal College of Psychiatrists
This Article
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Davies, T. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Davies, T. S.

A Monoamine Oxidase Inhibitor (Niamid) in the Treatment of the Mentally Subnormal

T. S. Davies, M.R.C.S., L.R.C.P., D.P.M., Consultant Psychiatrist

Llanfrechfa Grange Hospital, Newport, Mon.

ABSTRACT

Niamid, a monoamine oxidase inhibitor, was administered to a group of mentally subnormal patients in a hospital for such patients, and the effects clinically evaluated over a period of ten months. There is evidence that it has a stimulating effect on certain clinical types if they are apathetic, depressed or markedly regressed, in particular mongols, anergic schizophrenics and psychopaths.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals
Copyright © 1961 The Royal College of Psychiatrists.